153 related articles for article (PubMed ID: 11992630)
21. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more.
Sabisz M; Skladanowski A
Curr Pharm Biotechnol; 2008 Aug; 9(4):325-36. PubMed ID: 18691092
[TBL] [Abstract][Full Text] [Related]
22. DNA binding properties of the indolocarbazole antitumor drug NB-506.
Carrasco C; Vezin H; Wilson WD; Ren J; Chaires JB; Bailly C
Anticancer Drug Des; 2001; 16(2-3):99-107. PubMed ID: 11962518
[TBL] [Abstract][Full Text] [Related]
23. DNA intercalation by quinacrine and methylene blue: a comparative binding and thermodynamic characterization study.
Hossain M; Giri P; Kumar GS
DNA Cell Biol; 2008 Feb; 27(2):81-90. PubMed ID: 17924822
[TBL] [Abstract][Full Text] [Related]
24. Hetero-association of caffeine and aromatic drugs and their competitive binding with a DNA oligomer.
Davies DB; Veselkov DA; Djimant LN; Veselkov AN
Eur Biophys J; 2001 Sep; 30(5):354-66. PubMed ID: 11592692
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of cytotoxic natural product DNA intercalating agents by caffeine.
Hill GM; Moriarity DM; Setzer WN
Sci Pharm; 2011; 79(4):729-47. PubMed ID: 22145102
[TBL] [Abstract][Full Text] [Related]
26. Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity.
Kakuyama A; Sadzuka Y
Curr Drug Metab; 2001 Dec; 2(4):379-95. PubMed ID: 11766989
[TBL] [Abstract][Full Text] [Related]
27. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards.
O'Connor PM; Kohn KW
Cancer Commun; 1990; 2(12):387-94. PubMed ID: 2265064
[TBL] [Abstract][Full Text] [Related]
29. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
30. Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry.
Bedner E; Du L; Traganos F; Darzynkiewicz Z
Cytometry; 2001 Jan; 43(1):38-45. PubMed ID: 11122483
[TBL] [Abstract][Full Text] [Related]
31. Modulatory Effects of Caffeine and Pentoxifylline on Aromatic Antibiotics: A Role for Hetero-Complex Formation.
Woziwodzka A; Krychowiak-Maśnicka M; Gołuński G; Felberg A; Borowik A; Wyrzykowski D; Piosik J
Molecules; 2021 Jun; 26(12):. PubMed ID: 34198510
[TBL] [Abstract][Full Text] [Related]
32. Irreversible inhibition of calcium uptake in synaptosomes by quinacrine mustard: relationship to labeling sites of quinacrine mustard.
Ohta A; Baba A; Iwata H
J Neurochem; 1985 Aug; 45(2):657-60. PubMed ID: 4009180
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of anticancer effects and enhanced doxorubicin cytotoxicity of xanthine derivatives using canine hemangiosarcoma cell lines.
Motegi T; Katayama M; Uzuka Y; Okamura Y
Res Vet Sci; 2013 Oct; 95(2):600-5. PubMed ID: 23871419
[TBL] [Abstract][Full Text] [Related]
34. Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan.
Evstigneev MP; Mosunov AA; Evstigneev VP; Parkes HG; Davies DB
Eur Biophys J; 2011 Aug; 40(8):969-80. PubMed ID: 21674180
[TBL] [Abstract][Full Text] [Related]
35. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
[TBL] [Abstract][Full Text] [Related]
36. [Genetic control of mitotic crossing over in yeasts. IV. The induction of mitotic crossing over by chemical mutagens with different mechanisms of action].
Marfin SV; Zakharov IA
Genetika; 1983 Aug; 19(8):1227-32. PubMed ID: 6354843
[TBL] [Abstract][Full Text] [Related]
37. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells.
Hartley JA; Bingham JP; Souhami RL
Nucleic Acids Res; 1992 Jun; 20(12):3175-8. PubMed ID: 1620613
[TBL] [Abstract][Full Text] [Related]
38. Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents.
Murnane JP; Byfield JE; Ward JF; Calabro-Jones P
Nature; 1980 May; 285(5763):326-9. PubMed ID: 7374784
[TBL] [Abstract][Full Text] [Related]
39. Two New Mononuclear Copper(II)-Dipeptide Complexes of 2-(2'-Pyridyl)Benzoxazole: DNA Interaction, Antioxidation and in Vitro Cytotoxicity Studies.
Gan Q; Qi Y; Xiong Y; Fu Y; Le X
J Fluoresc; 2017 Mar; 27(2):701-714. PubMed ID: 27981404
[TBL] [Abstract][Full Text] [Related]
40. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
